Morphic (NASDAQ: MORF) Stock Skyrockets as Eli Lilly Offers 79% Premium in Acquisition Deal
Morphic (NASDAQ: MORF) stock surged during intraday trading Monday after Eli Lilly revealed plans to acquire a biopharmaceutical firm at […]
Morphic (NASDAQ: MORF) stock surged during intraday trading Monday after Eli Lilly revealed plans to acquire a biopharmaceutical firm at […]